Peptide record

TPDB03942

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB03942
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb AI4AVP dbAMP 3.0 DRAVP 2.0 ToxinPred 3.0
standard
No
A 14-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
INLKAIAALAKKLL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C70H130N18O16
RDCEQGHMFPSTWYV
AL
1479.91
10.84
3
0
10
+3
-0.96
1.157
195.71
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
0
0.00
1
Residue Composition
number
4
A
0
R
1
N
0
D
0
C
0
E
0
Q
0
G
0
H
2
I
4
L
3
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 4 R: 0 N: 1 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 2 L: 4 K: 3 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
14 reviewed residue count
C70H130N18O16 sequence-only estimate (linear, free termini)
1479.91 sequence-only estimate (linear, free termini)
10.84 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
-0.96 sequence-only estimate (linear, free termini)
1.157 sequence-only estimate (linear, free termini)
Evidence Records 68 records
Evidence 1 Activity

Activity

MIC
Antibacterial
25 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E. coli (MIC 25 uM) against fungi A. longipes (50% inhibition IC50 3 ug/ml), B. cinerea (IC50 6 ug/m), C. sp
Evidence 2 Activity

Activity

MIC
Antibacterial
32-64 µg/mL

Target

Staphylococcus aureus CCRC12652 or CCRC15211

Source & Reference

dbAMP DRAMP

Other

50 3 ug/m), T. viride (IC50 6 ug/m), and V. alboatrum (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml)
Evidence 3 Activity

Activity

MIC
Antibacterial
2 µg/mL

Target

S. xylosus

Source & Reference

dbAMP DRAMP

Other

m (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Am
Evidence 4 Activity

Activity

MIC
Antibacterial
16 µg/mL

Target

S. alactolyticus

Source & Reference

dbAMP DRAMP

Other

ainst Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCR
Evidence 5 Activity

Activity

MIC
Antibacterial
4 µg/mL

Target

C. koseri

Source & Reference

dbAMP DRAMP

Other

15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Chol
Evidence 6 Activity

Activity

MIC
Antibacterial
8 µg/mL

Target

Escherichia coli BL21 or JM109 Amp

Source & Reference

dbAMP DRAMP

Other

S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium C
Evidence 7 Activity

Activity

MIC
Antibacterial
128 µg/mL

Target

K.pneumoniae CCRC10694

Source & Reference

dbAMP DRAMP

Other

s (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelyti
Evidence 8 Activity

Activity

MIC
Antibacterial
32 µg/mL

Target

S. Choleraesuis

Source & Reference

dbAMP DRAMP

Other

ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and
Evidence 9 Activity

Activity

MIC
Antibacterial
32 µg/mL

Target

S. typhimurium CCRC12947

Source & Reference

dbAMP DRAMP

Other

mp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also activ
Evidence 10 Activity

Activity

MIC
Antibacterial
64 µg/mL

Target

V. parahamelytics CCRC10806

Source & Reference

dbAMP DRAMP

Other

(MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum
Evidence 11 Activity

Activity

MIC
Antibacterial
128 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP DRAMP

Other

S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC5
Evidence 12 Activity

Activity

IC50
Antibacterial
1-3 µM

Target

F. culmorum

Source & Reference

dbAMP DRAMP

Other

C 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 13 Activity

Activity

IC50
Antibacterial
13 µM

Target

S. cerevisiae

Source & Reference

dbAMP DRAMP

Other

sa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 14 Activity

Activity

IC50
Antibacterial
5 µM

Target

P. pastoris

Source & Reference

dbAMP DRAMP

Other

against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 15 Activity

Activity

MIC
Antifungal
25 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against E. coli (MIC 25 uM) against fungi A. longipes (50% inhibition IC50 3 ug/ml), B. cinerea (IC50 6 ug/m), C. sp
Evidence 16 Activity

Activity

MIC
Antifungal
32-64 µg/mL

Target

Staphylococcus aureus CCRC12652 or CCRC15211

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

50 3 ug/m), T. viride (IC50 6 ug/m), and V. alboatrum (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml)
Evidence 17 Activity

Activity

MIC
Antifungal
2 µg/mL

Target

S. xylosus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

m (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Am
Evidence 18 Activity

Activity

MIC
Antifungal
16 µg/mL

Target

S. alactolyticus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ainst Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCR
Evidence 19 Activity

Activity

MIC
Antifungal
4 µg/mL

Target

C. koseri

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Chol
Evidence 20 Activity

Activity

MIC
Antifungal
8 µg/mL

Target

Escherichia coli BL21 or JM109 Amp

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium C
Evidence 21 Activity

Activity

MIC
Antifungal
128 µg/mL

Target

K.pneumoniae CCRC10694

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

s (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelyti
Evidence 22 Activity

Activity

MIC
Antifungal
32 µg/mL

Target

S. Choleraesuis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and
Evidence 23 Activity

Activity

MIC
Antifungal
32 µg/mL

Target

S. typhimurium CCRC12947

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

mp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also activ
Evidence 24 Activity

Activity

MIC
Antifungal
64 µg/mL

Target

V. parahamelytics CCRC10806

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

(MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum
Evidence 25 Activity

Activity

MIC
Antifungal
128 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC5
Evidence 26 Activity

Activity

IC50
Antifungal
1-3 µM

Target

F. culmorum

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

C 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 27 Activity

Activity

IC50
Antifungal
13 µM

Target

S. cerevisiae

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

sa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 28 Activity

Activity

IC50
Antifungal
5 µM

Target

P. pastoris

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 29 Activity

Activity

MIC
Antiparasitic
25 µM

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
Active against E. coli (MIC 25 uM) against fungi A. longipes (50% inhibition IC50 3 ug/ml), B. cinerea (IC50 6 ug/m), C. sp
Evidence 30 Activity

Activity

MIC
Antiparasitic
32-64 µg/mL

Target

Staphylococcus aureus CCRC12652 or CCRC15211

Source & Reference

dbAMP 3.0 DRAMP

Other

50 3 ug/m), T. viride (IC50 6 ug/m), and V. alboatrum (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml)
Evidence 31 Activity

Activity

MIC
Antiparasitic
2 µg/mL

Target

S. xylosus

Source & Reference

dbAMP 3.0 DRAMP

Other

m (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Am
Evidence 32 Activity

Activity

MIC
Antiparasitic
16 µg/mL

Target

S. alactolyticus

Source & Reference

dbAMP 3.0 DRAMP

Other

ainst Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCR
Evidence 33 Activity

Activity

MIC
Antiparasitic
4 µg/mL

Target

C. koseri

Source & Reference

dbAMP 3.0 DRAMP

Other

15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Chol
Evidence 34 Activity

Activity

MIC
Antiparasitic
8 µg/mL

Target

Escherichia coli BL21 or JM109 Amp

Source & Reference

dbAMP 3.0 DRAMP

Other

S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium C
Evidence 35 Activity

Activity

MIC
Antiparasitic
128 µg/mL

Target

K.pneumoniae CCRC10694

Source & Reference

dbAMP 3.0 DRAMP

Other

s (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelyti
Evidence 36 Activity

Activity

MIC
Antiparasitic
32 µg/mL

Target

S. Choleraesuis

Source & Reference

dbAMP 3.0 DRAMP

Other

ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and
Evidence 37 Activity

Activity

MIC
Antiparasitic
32 µg/mL

Target

S. typhimurium CCRC12947

Source & Reference

dbAMP 3.0 DRAMP

Other

mp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also activ
Evidence 38 Activity

Activity

MIC
Antiparasitic
64 µg/mL

Target

V. parahamelytics CCRC10806

Source & Reference

dbAMP 3.0 DRAMP

Other

(MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum
Evidence 39 Activity

Activity

MIC
Antiparasitic
128 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP 3.0 DRAMP

Other

S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC5
Evidence 40 Activity

Activity

IC50
Antiparasitic
1-3 µM

Target

F. culmorum

Source & Reference

dbAMP 3.0 DRAMP

Other

C 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 41 Activity

Activity

IC50
Antiparasitic
13 µM

Target

S. cerevisiae

Source & Reference

dbAMP 3.0 DRAMP

Other

sa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 42 Activity

Activity

IC50
Antiparasitic
5 µM

Target

P. pastoris

Source & Reference

dbAMP 3.0 DRAMP

Other

against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 43 Activity

Activity

MIC
Antiviral
25 µM

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
Active against E. coli (MIC 25 uM) against fungi A. longipes (50% inhibition IC50 3 ug/ml), B. cinerea (IC50 6 ug/m), C. sp
Evidence 44 Activity

Activity

MIC
Antiviral
32-64 µg/mL

Target

Staphylococcus aureus CCRC12652 or CCRC15211

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

50 3 ug/m), T. viride (IC50 6 ug/m), and V. alboatrum (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml)
Evidence 45 Activity

Activity

MIC
Antiviral
2 µg/mL

Target

S. xylosus

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

m (IC50 6 ug/m). Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Am
Evidence 46 Activity

Activity

MIC
Antiviral
16 µg/mL

Target

S. alactolyticus

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

ainst Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCR
Evidence 47 Activity

Activity

MIC
Antiviral
4 µg/mL

Target

C. koseri

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Chol
Evidence 48 Activity

Activity

MIC
Antiviral
8 µg/mL

Target

Escherichia coli BL21 or JM109 Amp

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium C
Evidence 49 Activity

Activity

MIC
Antiviral
128 µg/mL

Target

K.pneumoniae CCRC10694

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

s (MIC 16 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelyti
Evidence 50 Activity

Activity

MIC
Antiviral
32 µg/mL

Target

S. Choleraesuis

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and
Evidence 51 Activity

Activity

MIC
Antiviral
32 µg/mL

Target

S. typhimurium CCRC12947

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

mp (MIC 8 ug/ml), K.pneumoniae CCRC10694 (MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also activ
Evidence 52 Activity

Activity

MIC
Antiviral
64 µg/mL

Target

V. parahamelytics CCRC10806

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

(MIC 128 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum
Evidence 53 Activity

Activity

MIC
Antiviral
128 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC5
Evidence 54 Activity

Activity

IC50
Antiviral
1-3 µM

Target

F. culmorum

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

C 64 ug/ml), and P.aeruginosa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 55 Activity

Activity

IC50
Antiviral
13 µM

Target

S. cerevisiae

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

sa (MIC 128 ug/ml). Also active against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 56 Activity

Activity

IC50
Antiviral
5 µM

Target

P. pastoris

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

against N. crassa, B. cinerea, F. culmorum (IC50 1-3 uM), S. cerevisiae (IC50 13 uM), and P. pastoris (IC50 5 uM).
Evidence 57 Activity

Activity

82% degranulation
Toxicity
10 µg/mL
Cytotoxic
82% degranulation | 10 | µg/mL | target cell: Rat mast cells

Target

Rat mast cells

Source & Reference

NA
DBAASP
The mastoparanogen from wasp | Peptides | 2006
Evidence 58 Activity

Activity

0% Hemolysis
Toxicity
32 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 32 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Evidence 59 Activity

Activity

3% Hemolysis
Toxicity
64 µg/mL
Hemolytic Cytotoxic
3% Hemolysis | 64 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 60 Activity

Activity

10% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
10% Hemolysis | 128 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 61 Activity

Activity

26% Hemolysis
Toxicity
256 µg/mL
Hemolytic Cytotoxic
26% Hemolysis | 256 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 62 Activity

Activity

0% Hemolysis
Toxicity
64 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 64 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 63 Activity

Activity

5% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
5% Hemolysis | 128 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Evidence 64 Activity

Activity

23% Hemolysis
Toxicity
256 µg/mL
Hemolytic Cytotoxic
23% Hemolysis | 256 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 65 Activity

Activity

50% Cell death
Toxicity
32 µg/mL
Cytotoxic
50% Cell death | 32 | µg/mL | target cell: Human embryonic kidney HEK293 cells

Target

Human embryonic kidney HEK293 cells

Source & Reference

NA
DBAASP
Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B. | Chem Biol Drug Des | 2016
Evidence 66 Activity

Activity

Toxicity
Hemolytic Cytotoxic
- | NA | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial peptides from the venom gland of the social wasp Vespa tropica. | Toxicon | 2013
Evidence 67 Activity

Activity

50% Cell death
Toxicity
>67.6 µM
Cytotoxic
50% Cell death | >67.6 | µM | target cell: CEM-SS cells

Target

CEM-SS cells

Source & Reference

NA
DBAASP
Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database | Antimicrob Agents Chemother | 2010
Evidence 68 Activity

Activity

% Hemolysis
Toxicity
0 %
Hemolytic
Hemolytic_activity: [Ref.27591703] 0% hemolysis at 64 µg/ml against human red blood cells 0% hemolysis at 32 µg/ml , 6% hemolysis at 64 µg/ml against sheep red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Biochem Pharmacol. 2005 Jul 15 70(2):209-219. ##Chem Biol Drug Des. 2017 Mar 89(3):327-338. doi: 10.1111/cbdd.12864.